Navigation Links
Governor Corbett Announces at Least 80 New Jobs in Lehigh Valley with Pharmaceutical Company's Purchase, Renovation of Former Amcor Site
Date:2/15/2011

HARRISBURG, Pa., Feb. 15, 2011 /PRNewswire-USNewswire/ -- Governor Tom Corbett today announced that the global pharmaceutical company Daiichi Sankyo Inc. will create more than 80 jobs in the Lehigh Valley with the establishment of its first U.S. manufacturing and packaging operation.

Daiichi Sankyo Inc. will buy and renovate the 140,000-square-foot former Amcor packaging facility and have it fully operational this fall. Once the facility is fully operational, it is expected to package the company's entire line of marketed products in the U.S.

"Creating and protecting family sustaining jobs in Pennsylvania is one of this administration's priorities, so I'm pleased to announce Daiichi Sankyo's decision to select Bethlehem for its first U.S. packaging and manufacturing plant," said Governor Corbett. "By creating more than 80 jobs, continuing the productive use of a facility that had been closed and injecting more than $15 million in private investment into the local economy, this project will positively impact the Lehigh Valley."

The total cost of the project – which includes the facility's purchase and renovation, new equipment acquisition, and employee training – is $19.6 million. The project will create at least 82 jobs in Bethlehem within three years.

DSI – formed in 2006 and headquartered in Parsippany, N.J. – is the U.S. subsidiary of global pharmaceutical company Daiichi Sankyo Co. Ltd.  DSI, which has nearly 3,000 U.S. employees, is focused on the development of cardiovascular and oncology therapies and concentrates in the therapy areas of hypertension, thrombosis, dyslipidemia, diabetes and acute coronary syndrome.

"This move diversifies our capabilities and allows us to streamline our operations and minimize commercialization risk by exerting greater control over the life cycle of our products, from research and development through packaging and distribution," said Jeff Lane, vice president of operations at Daiichi Sankyo. "We are excited to be opening a facility in Bethlehem and look forward to a productive future working relationship and becoming a part of the local community."

The project was coordinated by the Governor's Action Team, economic development professionals who work directly with businesses that are considering locating or expanding in the state.

The Lehigh Valley Economic Development Corp. and Northampton County helped the company obtain a $3.6 million funding offer from the commonwealth for the project. The package includes a $250,000 opportunity grant, a $2 million loan from the Pennsylvania Industrial Development Authority, a $1 million loan from the Machinery and Equipment Loan Fund, $100,000 in job training assistance and $246,000 in job creation tax credits.

"This is exactly the type of company we want to see in the Lehigh Valley," said Philip B. Mitman, president and CEO of Lehigh Valley Economic Development Corp. "Daiichi Sankyo will provide high quality jobs in one of our target industry clusters for growth in the region."

"This is a valuable addition to Northampton County," said John Stoffa, Northampton County executive. "We are excited that a global company of this caliber has chosen to locate and provide these 80 job opportunities to the citizens of our region. Thanks to the collaborative efforts of the county, LVEDC and the Governor's Action Team, another company has chosen to invest in our local economy, proving that the Lehigh Valley is the place to do business."  

For more information on Daiichi Sankyo, visit www.dsi.com.

For more information on the Governor's Action Team and other Department of Community and Economic Development programs, visit www.NewPA.com or call 1-866-466-3972.Media contacts:  Kevin Harley, 717-783-1116Luke Webber, DCED, 717-783-1132
'/>"/>

SOURCE Pennsylvania Department of Community & Economic Development
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. California Legislature Passes Historic HIV Testing Bill (AB 682); AHF Urges Governor to Sign Crucial Lifesaving Legislation
2. Governor Rendell Says Hundreds of Jobs Coming to York County as Medical Device Manufacturer Prepares to Expand
3. Governor Rendell: New State Investments Bear Fruit in Adams County; Help Pharmaceutical Company Expand in Philadelphia
4. Bayer HealthCare Pharmaceuticals Supports New Jersey Governors School in the Sciences at Drew University
5. CORRECTION - Governor Rendell Highlights Success of Health Care Reform Act as Seniors Get Rebate Checks to Help Pay for Prescription Drugs
6. National Pharmaceutical Council Comments on Patient-Centered Outcomes Research Institute Board of Governors
7. Governor Patrick, Life Sciences Center Celebrate Organogenesis New Headquarters
8. Governor Michael O. Leavitt, Former HHS Secretary and EPA Administrator, Selects WorldWide Speakers Group for Exclusive Representation
9. Ampac Fine Chemicals President Aslam Malik Joins SOCMAs Board of Governors; Industry Veteran Adds Significant Experience to Board
10. Aribex CEO Receives Utah Governors Medal
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... Pulmatrix, Inc . (NASDAQ: PULM), a clinical stage biopharmaceutical company ... announced that it has added two experts in the fields ... Scientific Advisory Board . The two experts ... MD, former chief of the Pediatric Pulmonary and Allergy Divisions ... University, and David Denning , MD, ...
(Date:3/27/2017)... SAN FRANCISCO , March 27, 2017 ...  is expected to reach USD 16.0 billion by 2025, ... Inc. The growing prevalence of chronic diseases is anticipated ... clinical chemistry analyzers, which thereby widens the scope for ... of geriatric and bariatric population, which is highly susceptible ...
(Date:3/27/2017)... DUBLIN and BOSTON ... AGN), a leading global pharmaceutical company and Paratek ... on the development and commercialization of innovative therapies ... Phase 3 trials of sarecycline for the treatment ... week primary efficacy endpoints. Sarecycline is a once-daily, ...
Breaking Medicine Technology:
(Date:3/27/2017)... VA (PRWEB) , ... March 27, 2017 , ... ... application containerization, today announced it will co-exhibit with technology partners LG Business Solutions ... at the Marriott Metro Center in Washington D.C., will provide education and examination ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... the CE Certificate of Conformity for the Smart System® 20/20. CE Certification builds ... highest industry standards and specifications such as ANSI, ISO and proven test methods ...
(Date:3/27/2017)... ... 2017 , ... Osteitis pubis may be commonplace and seemingly ... occurs when the muscles around the pelvis become inflamed. Over time, untreated osteitis ... as well as accompanying tenderness and weakness. Without proper intervention, it can hinder ...
(Date:3/27/2017)... ... March 27, 2017 , ... EpiGentek , a Farmingdale, ... recent RNA methylation “gold rush” with their established portfolio of optimized assay kits ... N6-methyladenosine, or m6A , RNA methylation has received a new burst in ...
(Date:3/27/2017)... San Mateo, CA (PRWEB) , ... March 27, 2017 , ... Janet Schloz is still ... one of the best days I’ve had in a long time,” she said. , She ... a lot of money that I never thought I would have to help my students.” ...
Breaking Medicine News(10 mins):